Publication|Articles|December 15, 2025
- Pharmaceutical Executive: December 2025
- Volume 45
- Issue 9
Pharmaceutical Executive: December 2025 Interactive Digital Edition
View the Pharmaceutical Executive December 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
5 months ago
A Year of Change5 months ago
Brent Saunders: Eyeing New Horizons5 months ago
The GLP-1 Gold Rush5 months ago
A Defining Period for M&A5 months ago
Is Manufacturing Coming Home?5 months ago
DTC Models and Momentum5 months ago
The Cost of Fixing PharmaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
2
Beyond the Molecule: The New Competitive Battlefield in Oncology
3
FDA Approves Beqalzi for Relapsed or Refractory Mantle Cell Lymphoma, Inqovi in Combination with Venetoclax
4
Pharmaceutical Executive Daily: Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu
5
